It’s More Than a Career, It’s a Mission.
Our people are the foundation of our success. By joining our growing team at Sarah Cannon Research Institute (SCRI), a subsidiary of McKesson, you will have the opportunity to become part of one of the largest community-based cancer programs to advance oncology treatments and improve outcomes for cancer patients across the globe. We look for mission-driven candidates who have a desire to advance the fight against cancer and make a difference in the lives of patients diagnosed with cancer every day.
Our Mission
People who live with cancer – those who work to prevent it, fight it, and survive it – are at the heart of every decision we make. Bringing the most innovative medical minds together with the most passionate caregivers in their communities, we are transforming care and personalizing treatment. Through clinical excellence and cutting-edge research, SCRI is redefining cancer care around the world.
As the Senior Site DevelopmentManager,you area strategic education partner to SCRI-supported research sites, addressing complex and evolving educational needs that cannot be met through standard onboarding or ongoing training programs. The Senior Manager provides targeted, high-impact education and support aligned to site-specific gaps, operational challenges, and regulatory expectations.
This roleoperatesin close collaboration with the SCRI Quality team and the Training & Education team to deliver coordinated, efficient, and scalable education solutions that enhance site performance, compliance, and clinical trial execution. The responsibilities of this position include:
Serves as a senior-level education partner supporting oncology research sites across thenetwork.
Delivers targeted, just-in-time education based on site-specific needs, performance trends, and emerginggaps.
Supports (but does not own) onboarding through supplemental education; site-specific onboarding/orientationremainsthe responsibility of thesite.
Collaborates closely with SCRI Quality and Training & Education teams to align content, priorities, and deliveryapproaches.
Enhances site capability in key areas such as protocol execution, GCP compliance, and operationalefficiency.
Manages a flexible portfolio of sites based on complexity and education needs (not a fixed assignment model)
Assess site-specific education needs based on performance data, audit trends, protocol complexity, and leadershipfeedback.
Develop and deliver focused education sessions (virtual and/or onsite) to address identifiedgaps.
Provide just-in-time education in response to emerging site needs, regulatory changes, or study-specificchallenges.
Reinforce critical concepts such as ICH GCP, protocol adherence, documentation standards, and patientsafety.
Own and continuously evolve the SCRI CRC Core Curriculum, aligning foundational and advanced training with regulatory expectations, quality insights, and site performance needs across thenetwork.
Partner with Research Site Partnership leaders and Quality team toidentifyperformance gaps that require educationintervention.
Translate KPI trends (e.g., enrollment challenges, deviations, data quality issues) into actionable educationplans.
Support sites in implementing improvements through education, coaching, and follow-upreinforcement.
Evaluate effectiveness of education through site feedback and performance improvementindicators.
Partner withSCRIQuality team to align education with audit findings, CAPAs, and risk mitigationefforts.
Collaborate withTraining& Education team to ensure consistency with enterprise curriculum and avoidduplication.
Contribute to development or refinement of standardized training materials based on recurring siteneeds.
Serve as a bridge between enterprise education strategy and real-time siteexecution.
Provide targeted onboarding support fornew staffor new-to-research team members through role-basededucation.
Deliver foundational and advanced topic training as needed (e.g., informed consent, AE/SAE reporting, source documentation)
Serve as a subject matter resource for complex research operationstopics.
Stay current on regulatory guidance (FDA, ICH GCP), oncology trial trends, and bestpractices.
Provide guidance during complex study start-up or execution phases whenadditionaleducation isrequired.
You should have for this position:
Abachelor’s degree,master’sdegree preferred
Experience working inoncologyclinicalresearch.
Experience in training, education delivery, or quality/audit support
Experience working in a matrixedenvironment.
Knowledge ofICH GCP, FDA regulations, and compliance expectations
Clinical trial operations across the site lifecycle
Knowledge of adult learning principles and education delivery methods
Knowledge of quality and audit processes in research
Education and facilitation (virtual and in-person)
Ability to simplify complex regulatory and operationaltopics
Data interpretation and ability to link KPIs to educationneeds
Collaboration and matrixed partnership skills
Communication andinfluencingwithoutauthority
Problem-solving and adaptability
About Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. In 2022, SCRI formed a joint venture with former US Oncology Research to expand clinical trial access across the country. It has conducted more than 850 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA in the past decade. SCRI’s research network brings together more than 1,300 physicians who are enrolling patients into clinical trials at more than 200 locations in 20+ states across the U.S. Please click here to learn more about our research offerings.
We care about the well-being of the patients and communities we serve, and that starts with caring for our people. That’s why we have a Total Rewards package that includes comprehensive benefits to support physical, mental, and financial well-being. Our Total Rewards offerings serve the different needs of our diverse colleague population and ensure they are the healthiest versions of themselves. For more information regarding benefits through our parent company, McKesson, please click here
As part of Total Rewards, we are proud to offer a competitive compensation package. This is determined by several factors, including performance, experience and skills, equity, regular job market evaluations, and geographical markets. In addition to base pay, other compensation, such as an annual bonus or long-term incentive opportunities may be offered.
McKesson has become aware of online recruiting-related scams in which individuals who are not affiliated with or authorized by McKesson are using McKesson’s (or affiliated entities, like CoverMyMeds or RxCrossroads) name in fraudulent emails, job postings or social media messages. In light of these scams, please bear the following in mind:
McKesson Talent Advisors will never solicit money or credit card information in connection with a McKesson job application.
McKesson Talent Advisors do not communicate with candidates via online chatrooms or using email accounts such as Gmail or Hotmail. Note that McKesson does rely on a virtual assistant (Gia) for certain recruiting-related communications with candidates.
McKesson job postings are posted on our career site: careers.mckesson.com
We are an equal opportunity employer and value diversity at our company. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status.
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations, conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted more than 850 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA in the past decade. SCRI’s research network brings together more than 1,300 physicians who are actively enrolling patients into clinical trials at over 200 locations in more than 20 states across the U.S.
